EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: PROS1 (p.Leu584Arg) pathogenic mutation causes portal and superior mesenteric venous thromboembolism

Peng Ding, Yuan Zhou, Kai-Chen Zhang, Sheng Li, Kun-Lan Long, Jun Chen, Ying-Jie Chen, Pei-Yang Gao

Frontiers in Cardiovascular Medicine · 14.11.2023 · 10

DOI: 10.3389/fcvm.2023.1277676 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 14.11.2023. Verfasst von Peng Ding und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Genetic and acquired risk factors are fundamental to developing venous thromboembolism. Autosomal dominant protein S deficiency caused by pathogenic mutations in the PROS1 gene is a well-known risk factor for thrombophilia. Case presentation We report a 30-year-old male patient who presented to the hospital with portal vein thrombosis. The patient had a history of abdominal pain for one month. Abdominal vascular CT showed venous thrombosis in the portal vein and superior mesenteric vein. He was diagnosed with “portal and superior mesenteric vein thrombosis, small bowel obstruction and necrosis, acute upper gastrointestinal bleeding (UGIB), hemorrhagic shock.” Serum protein S levels were decreased, and gene sequencing revealed a heterozygous missense mutation in PROS1, c.1571T > G (p.Leu584Arg). The patient received anticoagulation therapy with Enoxaparin Sodium and rivaroxaban, transjugular intrahepatic portosystemic shunt (TIPS), and ICU treatments. Although the patient had a severe bleeding event during anticoagulation therapy, he recovered well after active treatment and dynamic monitoring of anti-Xa.

Conclusion

Hereditary protein S deficiency caused by a mutation in the PROS1 gene is the genetic basis of this patient, and Enoxaparin Sodium and rivaroxaban have been shown to be highly effective.

Schlagwörter

Stichwörter der Autor:innen

PROS1case reportpathogenic mutationportal vein thrombosisprotein S deficiencysuperior mesenteric vein thrombosis

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Department of Geriatric Medicine, General Hospital of Western Theater Command, PLA, Chengdu, China.

Zitieren

APA

Ding, P., Zhou, Y., Zhang, K. C., Li, S., Long, K. L., Chen, J., Chen, Y. J., & Gao, P. Y. (2023). Case Report: PROS1 (p.Leu584Arg) pathogenic mutation causes portal and superior mesenteric venous thromboembolism. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1277676

Vancouver

Ding P, Zhou Y, Zhang KC, Li S, Long KL, Chen J, et al. Case Report: PROS1 (p.Leu584Arg) pathogenic mutation causes portal and superior mesenteric venous thromboembolism. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1277676

BibTeX
@article{Ding2023,
  author = {Ding, Peng and Zhou, Yuan and Zhang, Kai-Chen and Li, Sheng and Long, Kun-Lan and Chen, Jun and Chen, Ying-Jie and Gao, Pei-Yang},
  title = {Case Report: PROS1 (p.Leu584Arg) pathogenic mutation causes portal and superior mesenteric venous thromboembolism},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2023},
  volume = {10},
  doi = {10.3389/fcvm.2023.1277676}
}
Kostenlos starten →